Vanesa Sanchez-Guajardo - Publications

2008-2013 Biomedicine Aarhus University, Aarhus, Denmark 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Olesen MN, Christiansen JR, Petersen SV, Jensen PH, Paslawski W, Romero-Ramos M, Sanchez-Guajardo V. CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon. 4: e00513. PMID 29560431 DOI: 10.1016/j.heliyon.2018.e00513  1
2016 Christiansen JR, Olesen MN, Otzen DE, Romero-Ramos M, Sanchez-Guajardo V. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology. Journal of Neuroinflammation. 13: 74. PMID 27055651 DOI: 10.1186/s12974-016-0532-8  1
2015 Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience. PMID 25684748 DOI: 10.1016/j.neuroscience.2015.02.008  1
2014 Romero-Ramos M, von Euler Chelpin M, Sanchez-Guajardo V. Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance? Human Vaccines & Immunotherapeutics. 10: 852-67. PMID 24670306 DOI: 10.4161/hv.28578  1
2013 Sanchez-Guajardo V, Annibali A, Jensen PH, Romero-Ramos M. α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. Journal of Neuropathology and Experimental Neurology. 72: 624-45. PMID 23771222 DOI: 10.1097/NEN.0b013e31829768d2  1
2013 Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Experimental Neurology. 247: 45-58. PMID 23531432 DOI: 10.1016/j.expneurol.2013.03.017  1
2013 Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. Asn Neuro. 5: 113-39. PMID 23506036 DOI: 10.1042/AN20120066  1
2012 Barkholt P, Sanchez-Guajardo V, Kirik D, Romero-Ramos M. Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates. Neuroscience. 208: 85-96. PMID 22342967 DOI: 10.1016/j.neuroscience.2012.02.004  1
2010 Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease. Plos One. 5: e8784. PMID 20098715 DOI: 10.1371/journal.pone.0008784  1
2007 Sanchez-Guajardo V, Tanchot C, O'Malley JT, Kaplan MH, Garcia S, Freitas AA. Agonist-driven development of CD4+CD25+Foxp3+ regulatory T cells requires a second signal mediated by Stat6. Journal of Immunology (Baltimore, Md. : 1950). 178: 7550-6. PMID 17548589  1
2005 Marquez ME, Ellmeier W, Sanchez-Guajardo V, Freitas AA, Acuto O, Di Bartolo V. CD8 T cell sensory adaptation dependent on TCR avidity for self-antigens. Journal of Immunology (Baltimore, Md. : 1950). 175: 7388-97. PMID 16301646  1
2005 Sanchez-Guajardo V, Borghans JA, Marquez ME, Garcia S, Freitas AA. Different competitive capacities of Stat4- and Stat6-deficient CD4+ T cells during lymphophenia-driven proliferation. Journal of Immunology (Baltimore, Md. : 1950). 174: 1178-87. PMID 15661871  1
Show low-probability matches.